1. Home
  2. YSXT vs NSRX Comparison

YSXT vs NSRX Comparison

Compare YSXT & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo YSX Tech. Co. Ltd Class A Ordinary Shares

YSXT

YSX Tech. Co. Ltd Class A Ordinary Shares

N/A

Current Price

$1.38

Market Cap

41.4M

ML Signal

N/A

Logo Nasus Pharma Ltd. Ordinary Shares

NSRX

Nasus Pharma Ltd. Ordinary Shares

N/A

Current Price

$2.72

Market Cap

37.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
YSXT
NSRX
Founded
2011
2019
Country
China
Israel
Employees
N/A
N/A
Industry
Automotive Aftermarket
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.4M
37.1M
IPO Year
2023
2024

Fundamental Metrics

Financial Performance
Metric
YSXT
NSRX
Price
$1.38
$2.72
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $16.50
AVG Volume (30 Days)
3.0K
★ 14.0K
Earning Date
07-10-2026
08-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$5.57
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$1.98
52 Week High
$2.58
$9.50

Technical Indicators

Market Signals
Indicator
YSXT
NSRX
Relative Strength Index (RSI) 45.17 29.72
Support Level $1.21 $2.41
Resistance Level $1.31 $3.61
Average True Range (ATR) 0.08 0.23
MACD -0.02 -0.03
Stochastic Oscillator 39.18 4.49

Price Performance

Historical Comparison
YSXT
NSRX

About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares

YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services, and Software Development and Information Technology Services. Key revenue is generated from the Auto Insurance Aftermarket Value-added Services segment, which includes four types of value-added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services, and vehicle maintenance and other value-added services.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: